#earnings for the week https://t.co/lObOE0dgsr $PDD $ARRY $NKE $FL $GME $CSIQ $TME $CHWY $GIS $ACN $NIU $RVLP $WOOF $DRI $DOYU $ONON $ADMA $FDS $BZ $BRAG $AIR $KBH $DOOO $GAMB $CMC $EXPR $OLLI $HQY $BITF $ACDC $NVGS $HRTX $HUYA $AEVA $CTRN $WGO $LLAP $OXSQ $SMTI $XFOR $PHUN… https://t.co/EOYJrNpwDa https://t.co/U9g3hKYLg7
Adma Biologics activist said to support strategic review
4.81BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0008991046
CUSIP
000899104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
24.31
PEG Ratio
-
Book Value
1.57
Dividend Share
-
Dividend Yield
-
Earnings Share
0.84
Wall Street Target Price
29.49
EPS Estimate Current Year
0.60
EPS Estimate Next Year
0.96
EPS Estimate Current Quarter
0.13
EPS Estimate Next Quarter
0.16
Most Recent Quarter
-
Revenue TTM
459,380,992
Gross Profit TTM
241,542,000
EBITDA
159,943,008
Profit Margin
45.01%
Return On Assets TTM
22.06%
Return On Equity TTM
78.45%
Revenue Per Share TTM
1.952
Qtly Revenue Growth YOY
40.20%
Diluted Eps TTM
0.84
Qtly Earnings Growth YOY
41.40%
Trailing PE
24.31
Forward PE
28
Price Sales TTM
10.612
Price Book MRQ
12.8887
Enterprise Value Revenue
10
Enterprise Value EBITDA
29
164.51
9.27%587.59
1.14%241.47
1.05%79.75
0.75%289.81
0.20%434.32
0.08%562.00
0.00%175.75
0.00%87.81
-3.33%588.00
-1.44%